# The Therapeutic Effect of Co-administration of Pentoxifylline and Zinc in Men With Idiopathic Asthenozoospermia

> **NCT05178953** · EARLY_PHASE1 · UNKNOWN · sponsor: **Arak University of Medical Sciences** · enrollment: 160 (estimated)

## Conditions studied

- Men Infertility

## Interventions

- **DRUG:** Zinc Sulfate 220 mg Capsules
- **DRUG:** Pentoxifylline

## Key facts

- **NCT ID:** NCT05178953
- **Lead sponsor:** Arak University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-01
- **Primary completion:** 2022-01-08
- **Final completion:** 2022-01-20
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2022-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05178953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05178953, "The Therapeutic Effect of Co-administration of Pentoxifylline and Zinc in Men With Idiopathic Asthenozoospermia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05178953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*